Quality of life with melphalan/prednisone plus either thalidomide (MPT-T) or lenalidomide (MPR-R) in non-transplant eligible newly diagnosed multiple myeloma; results of the HOVON87/NMSG18 study

Claudia A.M. Stege (Oplægsholder), Kongsgaard Nielsen, L. (Andet), Birgit Witte (Andet), Bronno van der Holt (Andet), Ulf-Henrik Mellqvist (Andet), Morten Salomo (Andet), Gerard Bos (Andet), Mark-David Levin (Underviser), Heleen Visser-Wisselaar (Underviser), Markus Hansson (Underviser), Annette van der Velden (Underviser), Wendy Deenik (Andet), Astrid Gruber (Andet), Juleon Coenen (Oplægsholder), Plesner, T. (Oplægsholder), Saskia Klein (Andet), Bea Tanis (Andet), Damian L. Szatkowski (Andet), Rolf Brouwer (Andet), Matthijs Westerman (Andet), Rineke Leys (Andet), Harm Sinnige (Andet), Einar Haukås (Andet), Klaas van der Hem (Andet), Marc Durian (Andet), Vera Mattijssen (Andet), Peter Gimsing (Andet), Niels van de Donk (Andet), Marian Stevens-Kroef (Andet), Pieter Sonneveld (Andet), Anders Waage (Andet), Sonja Zweegman (Andet), Abildgaard , N. (Andet)

Aktivitet: Foredrag og mundtlige bidragKonferenceoplæg

Periode22. jun. 201725. jun. 2017
Begivenhedstitel22nd Congress of the European Hematology Association
BegivenhedstypeKonference
PlaceringMadrid, Spanien